Endothelial cell growth factor (ECGF) a was studied for its effects on bone formation in cultured fetal rat calvariae and on bone resorption in cultured fetal rat long bones.
Introduction
Bone formation is a complex process regulated by systemic hormones and by systemic and local growth factors. The effects of systemic hormones on bone formation have been studied extensively (1, 2) but only recently we have started to learn about the regulation of bone formation by systemic and local growth factors (2, 3) .
Local regulators of skeletal growth are factors, synthesized and released by bone or bone-related cells, that affect skeletal growth directly without the use ofthe circulatory system. Growth factors have been isolated from bone cultures and bone matrix and it is likely that a number of them are synthesized by bone or bone-related cells and act as autocrine or paracrine regulators of skeletal growth (4) (5) (6) . Local growth factors play an essential role in the regulation of tissue growth and this role may be at least as important as that played by the systemic hormones (7) . Furthermore, some of the effects of the systemic hormones on skeletal and nonskeletal tissue function are likely mediated by local factors, and hormones could act by modifying the synthesis or effects of a given local growth factor. same biological properties and significant amino acid homology and a-ECGF is identical to acidic FGF-2 (11, 12, and Burgess, W. H., and T. Maciag, unpublished observations). Although the source of this family of mitogens has been primarily the central nervous system, similar factors have been isolated from a variety of tissues (13) . A significant proportion of the growth factor activity present in bovine bone matrix is immunoprecipitated by antibodies to ECGF/acidic FGF (14) . This finding is important because it indicates that ECGF is either preferentially trapped by the bone matrix or is synthesized by skeletal cells. It was, therefore, critical to determine if ECGF had effects on bone remodelling and establish whether it is a local regulator ofskeletal growth. A growth factor with effects on bone formation, in addition to effects on endothelial cell replication and neovascularization, could play a significant role in bone remodelling and particularly in bone healing.
The present studies were undertaken to characterize the role of ECGF in bone formation and bone resorption. We assessed the direct effects of a-ECGF on bone DNA, collagen and noncollagen protein synthesis in rat calvarial cultures, and on 45Ca release in rat long bones.
Methods Boneformation
The method used to study effects on bone formation has been described in detail previously. One or two half calvariae from 21-d-old fetal rats were cultured in sterile 25-ml flasks containing 2 ml of Biggers Gwatkin medium modified by Fitton Jackson (BGJ medium) supplemented with bovine serum albumin (4 mg/ml; Reheis Chemical Co., Phoenix, AZ), 1 mM unlabeled proline (except for collagen degradation experiments), and 0.1 mM thymidine but no serum (15) . The flasks were gassed with 5% CO2 in air, sealed, and placed in a continuously shaking water bath at 37°C for periods of 24-96 h. a-ECGF was purified from bovine brain to homogeneity by the sequential use of ammonium sulfate fractionation, heparin sepharose chromatography, and reverse-phase high performance liquid chromatography (HPLC) as previously described (9) . a-ECGF was stored frozen in a solution of 33% acetonitrile and 0.1% trifluoroacetic acid (TFA) and 1 . Abbreviations used in this paper: BGJ medium, Biggers Gwatkin medium modified by Fitton Jackson; CDP, collagenase-digestible protein; ECGF, endothelial cell growth factor; NCP, noncollagenase-digestible protein; Pg, prostaglandin. diluted 1:650 or greater in BGJ medium. An equal amount of organic solvent was added to control calvariae. All experiments were performed with homogeneously pure a-ECGF except for one, presented in Table  I , in which the preparation used contained a small amount (<20%) of contaminant fl-ECGF, which is known to have the same biological effects as a-ECGF (9) . Hydroxyurea (Sigma Chemical Co., St. Louis, MO) and heparin (Ries Biologicals Inc, Irvine, CA) were added directly to BGJ medium, and indomethacin (Sigma Chemical Co.) was dissolved in absolute alcohol and diluted 1:10,000 in BGJ medium; an equal amount of alcohol was added to control cultures. Calvariae were continuously exposed to the agents studied unless specified otherwise. DNA To study effects on cell mitosis, calvariae were cultured and N-desacetyl-N-methyl colchicine (colcemid, 4 X 10-6 M; Gibco, Grand Island, NY) was added for the last 3 h ofthe culture period (17) . Calvariae were fixed in neutral formalin, embedded in paraffin, stained with hematoxylineosin, and sections examined at a magnification of250-400. Metaphasearrested cells were counted in at least two random cross sections taken from each one of five control and treated bone explants. Data are expressed as number of mitoses per section of half calvaria.
COLLAGEN AND NONCOLLAGEN (NCP) PROTEIN SYNTHESIS
Effects on newly synthesized collagen were determined by studying the incorporation of [2,3-3H]proline (5 gCi/ml; specific activity 25-40 Ci/ mmol; New England Nuclear) into total collagen and into type I collagen. Labeled proline was added for the last 2 h ofthe culture period, calvariae were extracted as described for DNA labeling and homogenized in 0.5 M acetic acid.
Total collagen synthesis. An aliquot ofthe homogenized calvaria was incubated with repurified bacterial collagenase (Worthington Biochemical Corp., Freehold, NJ) and the labeled proline incorporated into collagenase-digestible protein (CDP) and NCP was measured according to the method of Peterkofsky and Diegelmann (18) . Data are expressed as disintegrations per minute per microgram dry weight and as percent of control after dry weight correction. Percent collagen synthesis was calculated after multiplying NCP by 5.4 to correct for the relative abundance of proline in CDP and NCP (19).
Type I collagen synthesis. A pool offour homogenized halfcalvariae was digested with pepsin (1 mg/ml; Sigma Chemical Co.) in the presence of 1 mg of nonradioactive type I collagen over a 12-16-h period at 4°C; the collagen was precipitated with 2 M NaCl, dialyzed against 0.5 M acetic acid, and freeze-dried. An aliquot representing one calvaria and a radioactive type I collagen standard were dissolved in 0.5 M acetic acid, diluted in sample buffer, and the collagen chains were separated on a 6% polyacrylamide gel, according to a modification of the method described by Sykes et al. (20) . 2-Mercaptoethanol was applied to half of the gels 60 min after the electrophoresis was started (reduced collagen), while the other half was not treated (unreduced collagen). The gels were fixed and the protein profiles were displayed by fluorography.
COLLAGEN DEGRADATION
To study effects on collagen degradation, calvariae were cultured in control medium in the absence of unlabeled proline and treated with 5 ,Ci/ ml [3H]proline for a 24-h period. Bones were washed with BGJ medium containing 10 mM proline for 1 h and transferred to either control or ECGF (30 ng/ml-containing medium for a 3-, 6-, or 24-h "chase period". Calvariae were extracted (with TCA, acetone, and ether) and homogenized in 0.5 M acetic acid; an aliquot of this homogenate and of the respective culture medium was hydrolyzed in 6 N HCI at 1070C for 24 h. The samples were dried, derivatized with phenylisothiocyanate, and the [3HJproline ( The proportion of newly synthesized macromolecular collagen released from the bone into the medium during the pulse was determined in aliquots of the medium obtained during the 2-h [3H]proline pulse used in studies of collagen synthesis. The medium was exhaustively dialyzed in Spectrapor 3 dialysis tubing (Spectrum Medical, Los Angeles, CA; assigned molecular weight cut-off of 3,500) against 0.5 M acetic acid and analyzed for labeled CDP. Data are expressed as percent of CDP released to the medium.
PROSTAGLANDIN (Pg) E2 ASSAY
PgE2 was measured in the culture medium in triplicate using a specific radioimmunoassay (New England Nuclear). The cross-reactivity of the antibody was 3.7% with PgE, and <0.4% with other known prostaglandins or related compounds. PgE2 content was calculated from the linear portion ofthe binding curve. Data are expressed in nanomolar concentrations and as nanograms or picograms of PgE2 per half calvaria.
EFFECTS ON PERIOSTEUM AND PERIOSTEUM-FREE CALVARIA
These experiments were performed to compare effects on periosteal tissue, rich in fibroblasts and precursor cells, with those on the central calvaria, which is rich in osteoblasts (21, 22 
Bone resorption
Bone resorption was measured by the release of 45Ca from fetal rat long bones in culture as previously described (23) . Pregnant rats were injected with 0.2 mCi of 45Ca on the 18th day of pregnancy and sacrificed the following day. Radii and ulnae were dissected free of their cartilaginous ends and cultured in BGJ medium for 24 h. The bones were transferred to fresh medium and cultured in the continuous presence of a-ECGF (stored in 33% acetonitrile and 0.1 % TFA and diluted in BGJ medium 1:650 or greater) or control medium, containing an equal amount of organic solvent, for a 5-d period. At the completion ofthe culture period, the bones were dissolved in 5% TCA and 45Ca was quantitated in bone and medium. Bone resorption is expressed as percent of total radioactivity present in the medium over the culture period. (Fig. 1) . The effect was observed consistently at concentrations of 3 ng/ml, whereas at I ng/ml it was seen in about half of the experiments; at 100 ng/ml, the highest concentration tested, ECGF increased DNA labeling threefold. ECGF had no effect on the uptake of [3H]thymidine into the acid-extractable pool (data not shown) and ECGF at 1-100 ng/ml increased the number of metaphase-arrested cells after colcemid treatment (Table  I ). The time course of the ECGF effect on DNA labeling was tested by adding 30 ng/ml ECGF at various times before the end of a 24-h culture period; treatment with ECGF for 3 or 6 h was not effective but 12 h of exposure to ECGF resulted in a significant stimulation of[3Hj]thymidine incorporation into DNA (Fig. 2) . After 96 h of continuous treatment, ECGF stimulated Prostaglandin synthesis. ECGF also increased the PgE2 content in the medium of cultured calvariae. This effect was dose dependent and observed as early as 3 h after ECGF (30 ng/ml) treatment (Fig. 6) . The PgE2 concentration in control bones cultured for 24 h was (mean±SE; n = 6) 0.7±0.2 nM or 249±81 pg/half calvaria; in the presence of ECGF at 10-100 ng/ml for a 6-h period the PGE2 concentration increased from 2.8±0.4 to 11.7±2.4 nM or from 973±128 to 4,107+837 pg/half calvaria respectively (Fig. 6 B) . The stimulatory effect of ECGF on PgE2 synthesis was sustained for 96 h and it became more pronounced as calvariae were treated for longer periods of time. When PgE2 concentrations were measured at 24-h intervals in the medium of calvariae cultured for 96 h in control or in the continuous presence of 30 ng/ml ECGF, the agent increased PgE2 levels about twofold in the first 24-h period and about ninefold in the last 24-h period.
Although the stimulatory effect of ECGF on PgE2 synthesis appeared before the effect on DNA synthesis, the two effects did (Table V) . Bone resorption Treatment with ECGF at 1-100 ng/ml for a 5-d period did not increase "5Ca release from fetal rat long bones (Table VI) , indicating lack ofan ECGF effect on bone resorption in this system.
Discussion
The present studies were undertaken to examine the effects of ECGF on bone formation and bone resorption in vitro. ECGF stimulated DNA synthesis in cultures of fetal rat calvariae because it increased the incorporation of [3H~thymidine into acidprecipitable material, the bone DNA content, and the number of metaphase-arrested cells after colcemid arrest. Recent data have shown that heparin increases the affinity of ECGF to its Figure 5 . (21, 22, 24) . About 20% of the newly synthesized collagen was released to the culture medium over a 24-h period and most of it was in fully degraded form. Only a small proportion of macromolecular collagen appeared in the culture medium during the [3H]proline pulse or during a 24-h chase period, indicating that most of the newly synthesized collagen is laid on the bone matrix and the jettison of the intact molecule does not occur in this culture model to any significant extent. ECGF did not increase bone collagen degradation in cultured calvariae or the release of 45Ca from fetal rat long bones, which indicated that it has no effect on matrix degradation or bone resorption in these models. However, the stimulatory effect ofECGF on PgE2 synthesis could result in a stimulation of bone resorption in neonatal mouse calvariae, because in this model prostaglandins frequently mediate growth factor-stimulated bone resorption (26). The effects of ECGF on bone remodelling in vitro are different from those of other known growth factors including epidermal growth factor, platelet-derived growth factor, insulinlike growth factor I/Somatomedin-C and bone-derived growth factor (15, (27) (28) (29) (30) . Interleukin-1, which has limited amino acid sequence homology with acidic FGF (31) , stimulates bone resorption and has stimulatory effects on collagen synthesis in 24-h cultures, whereas in 96 h cultures it is inhibitory and these effects are temporarily opposite to those of ECGF (32, 33) . Transforming growth factor-,B is the only growth factor that has effects resembling those of ECGF on bone formation, but it has been shown to stimulate bone resorption in mouse calvariae, an effect not reported in fetal rat long bones (26, 34) .
The stimulatory effects of ECGF on endothelial cell replication and neovascularization in correlation with those on bone cell replication may be important for bone repair, particularly after fractures. Moreover, the mitogenic effect of ECGF on endothelial and bone cells is enhanced by heparin, and the fracture callus is rich in heparin-containing mast cells (35). Heparin increases the binding of ECGF to its receptor and this could have significant physiological implications in the process of bone repair, particularly if mast cell degranulation and heparin release occur at the fracture site. ECGF may also be important in osteoinduction, observed with matrix-derived factors (5), and its effects on cell replication and neovascularization may be essential for this process. ECGF/acidic FGF is present in bone matrix (14) , but synthesis by bone cells has not as yet been demonstrated. Studies to address this question are currently being performed in our laboratory and they will be necessary before we can conclude that ECGF is a true local regulator of skeletal growth. Whether ECGF is trapped by bone matrix or is synthesized by bone cells, its significant concentrations in this tissue combined with its effects on bone cell replication make it an important regulator of skeletal remodelling. Moreover, ECGF may be essential for normal bone repair.
In conclusion, ECGF stimulates bone DNA synthesis, an effect that results in an increased number of cells capable of synthesizing bone matrix proteins but ECGF has no effect on bone matrix degradation or bone resorption.
